FDA 483 - MESI D.O.O. - February 07, 2019

An FDA inspection of MESI D.O.O., a medical device manufacturer in Ljubljana, Slovenia, from February 4-7, 2019, identified one significant observation. The firm was cited for failing to develop and implement written Medical Device Reporting (MDR) procedures. This indicates a deficiency in their post-market surveillance system.